Premium
Effects of the beta‐adrenergic agonist, ritodrine, and insulin on plasma potassium concentrations in fetal lambs
Author(s) -
Bassett JM,
Bomford J,
Hanson C,
Mott JC,
Weeding CM
Publication year - 1992
Publication title -
experimental physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.925
H-Index - 101
eISSN - 1469-445X
pISSN - 0958-0670
DOI - 10.1113/expphysiol.1992.sp003626
Subject(s) - ritodrine , endocrinology , medicine , fetus , agonist , insulin , alpha (finance) , beta (programming language) , chemistry , receptor , pregnancy , gestation , biology , construct validity , genetics , nursing , computer science , patient satisfaction , programming language
Prolonged infusion of the beta 2‐adrenergic agonist, ritodrine, into sheep during late pregnancy decreased maternal plasma K+ from 3.6 to 2.5 mmol l‐1 during the first 6‐8 h of infusion, as it does during tocolysis in women. This decrease was not accompanied by significant change in fetal plasma K+ concentration. Ritodrine infusion (1‐3.5 micrograms kg‐1 min‐1) directly into the fetus also did not decrease fetal plasma K+ significantly. In contrast, insulin (2.5 mU kg‐1 min‐1), infused together with glucose (3.6 mg kg‐1 min‐1) directly into the fetus decreased fetal plasma K+ concentration by 0.8 mmol l‐1 within 1 h. The results suggest immaturity in beta 2‐adrenergic receptor regulation of electrogenic K+ uptake by muscle in fetal lambs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom